1. Home
  2. RGTIW vs IOVA Comparison

RGTIW vs IOVA Comparison

Compare RGTIW & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rigetti Computing Inc.

RGTIW

Rigetti Computing Inc.

HOLD

Current Price

$11.44

Market Cap

0.0

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.85

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGTIW
IOVA
Founded
2013
2007
Country
United States
United States
Employees
140
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
968.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGTIW
IOVA
Price
$11.44
$2.85
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$10.45
AVG Volume (30 Days)
850.8K
11.3M
Earning Date
03-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,892,000.00
$250,425,000.00
Revenue This Year
N/A
$60.71
Revenue Next Year
N/A
$59.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
175.62
52 Week Low
$4.28
$1.64
52 Week High
$4.75
$8.15

Technical Indicators

Market Signals
Indicator
RGTIW
IOVA
Relative Strength Index (RSI) 40.51 69.24
Support Level $11.00 $2.08
Resistance Level $16.26 $2.60
Average True Range (ATR) 1.87 0.17
MACD 0.15 0.07
Stochastic Oscillator 4.93 87.36

Price Performance

Historical Comparison
RGTIW
IOVA

About RGTIW Rigetti Computing Inc.

Rigetti Computing Inc is engaged in the business of full-stack quantum computing. The company offers full-stack quantum computing platform as a cloud service to a wide range of end-users, directly through its Rigetti QCS platform, and also through cloud service providers. Its proprietary quantum-classical infrastructure provides ultra-low latency integration with public and private clouds for high-performance practical quantum computing. The company has developed the industry's first multi-chip quantum processor for scalable quantum computing systems. Geographically, the company derives the majority of its revenue from the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: